EcoDrugPlus

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSOKIG00005000322
Gene Symbol: GRIK5
3 Cross references
227 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSOKIG00005034498
Gene Symbol: GRIK5
3 Cross references
222 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSOKIG00005016453
Gene Symbol: GRM2
3 Cross references
201 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSOKIG00005014662
Gene Symbol: GRM2
3 Cross references
201 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSOKIG00005047297
Gene Symbol: GRM4
1 Cross references
190 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSOKIG00005000180
Gene Symbol: GRM4
3 Cross references
203 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSOKIG00005003510
Gene Symbol: GRM4
3 Cross references
203 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSOKIG00005038876
Gene Symbol: GRM4
1 Cross references
190 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSOKIG00005037423
Gene Symbol: GRM5
1 Cross references
211 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSOKIG00005012063
Gene Symbol: GRM5
1 Cross references
212 Possible Orthologues:

Glutamate Receptor 1

Ensembl ID : ENSOKIG00005007238
Gene Symbol: LOC109893020
3 Cross references
242 Possible Orthologues:

Glutamate Receptor 1

Ensembl ID : ENSOKIG00005037097
Gene Symbol: LOC109864941
3 Cross references
244 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).